Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study.

Saito, Jumpei; Yakuwa, Naho; Ishizuka, Tatsuo; Goto, Mikako; Yamatani, Akimasa; Murashima, Atsuko

Saito, Jumpei; Yakuwa, Naho; Ishizuka, Tatsuo; Goto, Mikako; Yamatani, Akimasa; Murashima, Atsuko.

Afiliação

Saito J; Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan.
Yakuwa N; Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.
Ishizuka T; Center of General Internal Medicine and Rheumatology, Gifu Municipal Hospital, Gifu, Japan.
Goto M; Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.
Yamatani A; Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan.
Murashima A; Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.

Breastfeed Med ; 15(7): 475-477, 2020 07.

Article em En | MEDLINE | ID: mdl-32326740

Assuntos

Anticorpos Monoclonais Humanizados/sangue; Aleitamento Materno; Imunossupressores/sangue; Leite Humano/química; Doença Mista do Tecido Conjuntivo/tratamento farmacológico; Adulto; Animais; Anticorpos Monoclonais; Feminino; Humanos; Lactente

Palavras-chave

belimumab; breastfeeding; mixed connective tissue disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Animals / Female / Humans / Infant Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google